tiprankstipranks
Trending News
More News >
Rocket Pharmaceuticals Faces Legal Storm Over Trial Omission
PremiumClass ActionRocket Pharmaceuticals Faces Legal Storm Over Trial Omission
22d ago
Rocket Pharmaceuticals price target lowered to $11 from $34 at Canaccord
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $11 from $34 at Canaccord
1M ago
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
Premium
Weekend Updates
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
1M ago
Broadcom, Arista Networks initiated: Wall Street’s top analyst calls
PremiumThe FlyBroadcom, Arista Networks initiated: Wall Street’s top analyst calls
1M ago
Goldman downgrades Rocket to Sell on ‘surprising and concerning’ update
Premium
The Fly
Goldman downgrades Rocket to Sell on ‘surprising and concerning’ update
1M ago
Rocket Pharmaceuticals downgraded to Sell from Neutral at Goldman Sachs
Premium
The Fly
Rocket Pharmaceuticals downgraded to Sell from Neutral at Goldman Sachs
1M ago
Hold Rating for Rocket Pharmaceuticals Amid Safety Concerns and Financial Uncertainties
PremiumRatingsHold Rating for Rocket Pharmaceuticals Amid Safety Concerns and Financial Uncertainties
1M ago
Rocket Pharmaceuticals downgraded to Hold from Buy at Jefferies
Premium
The Fly
Rocket Pharmaceuticals downgraded to Hold from Buy at Jefferies
1M ago
Hold Rating Issued for Rocket Pharmaceuticals Amid Uncertainty Following Clinical Hold on RP-A501 Trial
Premium
Ratings
Hold Rating Issued for Rocket Pharmaceuticals Amid Uncertainty Following Clinical Hold on RP-A501 Trial
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100